The S-1 is filed. The bankers are named. That’s a different story than where Anthropic stood two
weeks ago.
Anthropic submitted a confidential draft registration statement on Form S-1 to the SEC on June 1,
2026, following the close of its $65B Series H round on May 28. Those events were reported last
week. What’s new, according to Bloomberg reporting cited by PYMNTS, is the underwriter lineup:
Morgan Stanley, Goldman Sachs, and JPMorgan Chase are reportedly leading the syndicate. All three
are bracket underwriters. You don’t assemble that team for a deal you’re testing the waters on.
The October 2026 window, attributed to bankers, not to Anthropic, now has institutional weight
behind it. Anthropic hasn’t publicly committed to a date. But when the banks building your order
book say October, October is the working assumption.
A few numbers matter here, and one distinction matters more than most analysts are flagging. Anthropic has reported annualized recurring revenue of approximately $47B as of May 2026. That
figure reflects contracted and committed revenue run-rates, not recognized revenue. The Wall Street
Journal has estimated net revenue at approximately $10.9B. Both numbers are real. They measure
different things. The gap between them, roughly $36B, is the accounting methodology question
that institutional investors will press hardest during roadshow. Any S-1 prospectus will need to
define which metric Anthropic uses as its headline revenue figure and why, and the answer will
shape how the company’s valuation is read against public-market comparables.
What to Watch
The reported post-money valuation from the Series H round is $965B. The Series H itself, at $65B,
closed May 28. These figures come from prior pipeline reporting; the primary S-1 source URL was
not accessible as of publication.
Context worth carrying forward: Anthropic isn’t the only frontier lab heading toward public
markets. OpenAI is reportedly targeting Q4 2026 near a $1T valuation. xAI’s investor roadshow is reportedly starting June 8.
Three labs. One window. The convergence makes each company’s differentiating risk profile more
important, not less, a question the deeper comparative analysis below addresses.
There’s also a demand-side headwind worth noting. Axios has reported growing corporate “AI
sticker shock”, enterprises pulling back on AI spending commitments they’d made earlier in the
year. Analysts have flagged this as a potential headwind for Anthropic’s revenue growth story
ahead of the IPO, particularly given the ARR-to-net-revenue gap.
Verification
Partial Bloomberg/PYMNTS (T3); Anthropic S-1 primary URL broken as of publication Underwriter names, October timeline, and all financial figures are reported, not verified against primary source documents as of publicationWhat to watch
The S-1 keeps share count, pricing, and capital raise targets confidential, as is
standard for this stage. The next visible milestone is the S-1 going effective, when Anthropic
files the public version, the specific financial disclosures will land simultaneously. That moment,
not the October date, is when the valuation debate becomes data-driven.
The catch is this: the ARR/$47B figure will be the headline number in coverage, and the $10.9B
WSJ net revenue estimate will be the footnote. Every prior Anthropic funding cycle played out
this way. Investors who anchor to the ARR without pricing the methodology discount into their
models are taking on a risk that isn’t reflected in the $965B valuation headline. Watch whether
the prospectus leads with ARR or net revenue. That editorial choice will tell you more about
Anthropic’s IPO strategy than the October date does.